Stephen Langabeer. “Molecular Screening for an Underlying Myeloproliferative Neoplasm in Rheumatology Patients”. Archives of Rheumatology, vol. 37, no. 3, Sept. 2022, pp. 475-6, doi:10.46497/ArchRheumatol.2022.9274.